Thermo Fisher Scientific
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Diagnostics & Research
業務概覽 Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
公司地址 168 Third Avenue, Waltham, MA, USA, 02451
電話號碼 +1 781 622-1000
傳真號碼 +1 781 622-1207
公司網頁 https://www.thermofisher.com
員工數量 125000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. James R. Meyer Senior Vice President and Chief Financial Officer -- 23/07/2025
Mr. Joseph R. Holmes Vice President and Chief Accounting Officer -- 26/02/2026
Mr. Gianluca Pettiti Co-Chief Operating Officer and President 美元 956.56K 12/01/2026
Mr. Stephen Williamson Senior Vice President and Chief Financial Officer 美元 1.05M 26/02/2026
Mr. Thomas B. Shropshire, Jr Senior Vice President and General Counsel -- 26/02/2026
Mr. Lisa P. Britt Senior Vice President and Chief Human Resources Officer -- 26/02/2026
Mr. Michel Lagarde Executive Vice President and Co-Chief Operating Officer 美元 1.13M 12/01/2026
Mr. Marc N. Casper Chairman of the Board and Chief Executive Officer 美元 1.74M 12/01/2026
Mr. Michael D. Shafer Executive Vice President -- 12/01/2026
 
董事會成員
董事會 職務 更新日期
Mr. Scott M. Sperling Lead Independent Director 26/02/2026
Ms. Jennifer M. Johnson Independent Director 26/02/2026
Dr. C. Martin Harris,M.D. Independent Director 26/02/2026
Ms. R. Alexandra Keith Independent Director 26/02/2026
Mr. Dion J. Weisler Independent Director 26/02/2026
Ms. Karen S. Lynch Director 26/02/2026
Dr. Debora L. Spar Independent Director 26/02/2026
Professor Dr. Tyler E. Jacks, PhD Director 26/02/2026
Mr. James C. Mullen Independent Director 26/02/2026
Ms. Ruby R. Chandy Independent Director 26/02/2026
Mr. Nelson J. Chai Independent Director 26/02/2026
Mr. Marc N. Casper Chairman of the Board and Chief Executive Officer 12/01/2026
 
所屬ETF (更新日期: 07/03/2026 04:03)
代號 名稱 佔比% ▼ 持有日期
BXMXNuveen S&P 500 Buy-Write Income0.01%31/12/2025
XYLDGlobal X S&P 500® Covered Call ETF0.01%27/02/2026
TCHPT. Rowe Price Blue Chip Growth ETF0.01%31/01/2026
GSUSGoldman Sachs MarketBeta US Equity ETF0.01%27/02/2026
LRGEClearBridge Large Cap Growth Select ETF0.01%27/02/2026
UPROProShares UltraPro S&P5000.005%27/02/2026
THWabrdn World Healthcare0.005%31/01/2026
TSPAT. Rowe Price US Equity Research ETF0.005%31/01/2026
BBHLBBH Select Large Cap ETF0.004%28/02/2026
FQALFidelity Quality Factor ETF0.004%27/02/2026
CGNGCapital Group New Geography Equity ETF0.004%31/01/2026
IYYiShares Dow Jones US ETF0.004%28/02/2026
SPYXSttStrt® SPDR® S&P®500FsslFulRsrvFreeETF0.004%27/02/2026
ETJEV Risk-Mgd Divers Equity Inc0.004%31/12/2025
IWLiShares Russell Top 200 ETF0.004%28/02/2026
FFLCFidelity Fundamental Large Cap Core ETF0.004%27/02/2026
DLNWisdomTree US LargeCap Dividend ETF0.004%27/02/2026
ILCViShares Morningstar Value ETF0.004%28/02/2026
CRFCornerstone Total Return0.004%31/12/2025
SFLRInnovator Equity Managed Floor ETF0.004%27/02/2026
  1    2    3    4   5    6    7    8    9    10    11    12    13    14    15    16    17    18    19  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.